Last update :
08/05/2024
Anticancer drug   Pembrolizumab  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Keytruda Argentina, Belgium, Chile, Ecuador, France, Germany, Great Britain, Italy, Mexico, Peru, Romania, Spain, Switzerland, Turkey, United States of America
References   Injection   References : Pembrolizumab  
Type Publication
2296 Manufacturer Témocilline (Negaban®) - Résumé des caractéristiques du produit
Eumedica 2017
3771 Manufacturer Pembrolizumab (Keytruda®) - Summary of Product Characteristics
Merck Sharp Dohme 2017
4334 Journal Sundaramurthi P, Sean Chadwick S, Narasimhan C.
Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag.
J Oncol Pharm Practice 2020 ; 26, 3: 641-646.
4786 Poster Avrillon K, Le Guyader G, Doillet H, Jaskowiec C, Paul M, Poullain S.
Etude de stabilité de solutions de pembrolizumab à 1 et 4 mg/mL à 5 et 25°C dans des poches de NaCl 0,9% en polyoléfine .
SFPO Congress 2023

  Mentions Légales